Advancements in Alzheimer’s disease: What is on the Horizon?

October 9, 2019
6:00 pm – 7:00 pm

Instituto Cervantes
31 West Ohio Street, Chicago, IL 60654, USA

Register Now

Share


Scientists perspectives on working Advancements in Alzheimer’s disease

About this Event

By Dr. Ismael Santa-María Pérez, Assistant Professor of Pathology and Cell Biology, Columbia University, New York

In collaboration with ECUSA (Españoles científicos en EE.UU.)

The MidWest Science & Innovation Cervantes Network is an effective science monthly meeting created to improve the relationship between science and society. It is an inclusive community of scientists, engineers, economists, public health specialists, and sciences enthusiasts across the Midwest.

While our events are focused on Spanish speaking countries scientists, we also welcome anyone interested in science. Most of our events attract a mix of professionals and students.

MidWest Science & Innovation Cervantes Network is excited to be hosting a premiere fall mixer dedicated to bringing the community together, making new connections and talking all things. Whether you’re a scientist enthusiast, looking to take the next step in your career or just interested in meeting people with similar interests… We’ve got you covered! Join us for a night of new connections.

The evening will include a keynote Dr. Ismael Santa-María Pérez, Assistant Professor of Pathology and Cell Biology, Columbia University, New York, who will share their perspectives on working Advancements in Alzheimer’s disease.

Dr. Ismael Santa-María Pérez

Dr. Santa-María Pérez is a biochemist with a Ph.D. in Molecular Biology from the Severo Ochoa Centre for Molecular Biology (Madrid, Spain). Currently, he is an assistant professor at Columbia University, faculty in the Alzheimer’s disease Research Center and member of the Taub Institute in New York. He heads a research laboratory investigating the role of microRNAs and post-transcriptional regulation in the onset and progression of neurodegenerative diseases. His entire scientific career has been focused on understanding the mechanisms maintaining or altering tau proteostasis in neurons, and their relevance in aging and Alzheimer’s disease (AD).